← Latest Filings
K

Kemula Pierre Thadee Victor

Chief Financial Officer

Open-market buys
3
$86K total
Open-market sells
0
$0 total
Tracking since
Oct 2026
Open-market buy — $17K
AgomAb Therapeutics NV · Oct 6, 2026
Open-market buy — $43K
AgomAb Therapeutics NV · Oct 6, 2026
Open-market trades from the last two years.
10,000 Common shares in AGMB
Held directly · as of 2026-10-06
AgomAb Therapeutics NV
CIK 0002020932